Gennex Laboratories Reconstitutes Key Board Committees
Gennex Laboratories Ltd 路 Intimation 路 15 Nov 2026, 12:23 am
Gennex Laboratories Reconstitutes Key Board Committees Gennex Laboratories Limited reconstituted its Audit Committee, Stakeholders Relationship Committee, and Nomination and Remuneration Committee with immediate effect during its board meeting on 14th Nov'26. Across all three committees, Non-Executive Independent Director Dilip Raj Singhvi serves as Chairman. Non-Executive Independent Directors Dipankar Dasgupta and Khushbu Kachhawa, along with Non-Executive Non-Independent Director Avasarala Ranga Rao Pantulu, serve as members.
Original exchange filing (PDF)
More announcements from Gennex Laboratories Ltd
- Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., November .... 路 15 Nov 2026
- 1. Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Half year ended September 30, 2026 along with the Statement of Assets and Liabilities as at September 30, .... 路 14 Nov 2026
- The Board of Directors of the Company at its meeting held today, i.e. Saturday, November 14, 2026 has considered and approved the following items: 1. Unaudited (Standalone and Consolidated) .... 路 14 Nov 2026
- Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. Consider and adopt the .... 路 14 Nov 2026
- In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time, please find enclosed herewith voting results of the 41st eAGM of the Company held on September .... 路 01 Oct 2026
- Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that the Company has received approval of its members by Special .... 路 30 Sept 2026
- Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of 41st eAGM of the Company held on Wednesday, September 30, 2026 through .... 路 30 Sept 2026
- We are pleased to inform that our subsidiary company, M/s Deccan Remedies Limited has received approval from the Drugs Control Administration, Government of Andhra Pradesh granting License .... 路 08 Sept 2026
